AntriaBio
Stage
Reverse Merger | IPOTotal Raised
$2.64MAbout AntriaBio
AntriaBio offers the diabetes product candidate, AB101, a once-a-week injectable basal insulin that is currently in preclinical development. AB101 is administered by subcutaneous injection and targets patients with type 1 and type 2 diabetes who require basal insulin for the control of hyperglycemia. In February 2013, Fits My Style merged with AntriaBio. Due to the merger, AntriaBio is now listed and trading on the OTC Bulletin Board and the OTCQB under the symbol "FMYY."
Loading...
Loading...
AntriaBio Patents
AntriaBio has filed 9 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/15/2017 | 2/18/2020 | Fluid dynamics, Dosage forms, Colloidal chemistry, Drug delivery devices, Aerodynamics | Grant |
Application Date | 9/15/2017 |
|---|---|
Grant Date | 2/18/2020 |
Title | |
Related Topics | Fluid dynamics, Dosage forms, Colloidal chemistry, Drug delivery devices, Aerodynamics |
Status | Grant |
Latest AntriaBio News
Apr 12, 2018
LOUISVILLE – Rezolute Inc., the bioscience company based in Louisville and formerly known as AntriaBio Inc., has laid off about half of its roughly 50-employee staff and has eliminated its manufacturing operation. The Daily Camera reports that the layoffs came less than a week after Rezolute announced it had raised $5 million on a round of convertible note financing to be used for working capital as well as the appointment of Hoyoung Huh as company vice chairman. It’s unclear whether the financing and board appointment are related to the layoffs.
AntriaBio Frequently Asked Questions (FAQ)
Where is AntriaBio's headquarters?
AntriaBio's headquarters is located at 890 Santa Cruz Ave, Menlo Park.
What is AntriaBio's latest funding round?
AntriaBio's latest funding round is Reverse Merger.
How much did AntriaBio raise?
AntriaBio raised a total of $2.64M.
Who are the investors of AntriaBio?
Investors of AntriaBio include Fits My Style.
Loading...
Loading...